文献速递心脑血管急症重症综合管理与镇静镇痛

丙戊酸联合心脏骤停后低温目标温度管理可预防迟发性癫痫发作并改善大鼠心脏骤停模型生存率

Valproic Acid Combined With Postcardiac Arrest Hypothermic-Targeted Temperature Management Prevents Delayed Seizures and Improves Survival in a Rat Cardiac Arrest Model.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论大鼠窒息性心脏骤停模型中,ROSC后5分钟启动丙戊酸300 mg/kg IV联合33°C低温目标温度管理可降低72小时癫痫发作发生率并提高72小时生存率。

该研究为前瞻性随机实验研究,纳入复苏成功的雄性Long Evans大鼠窒息性心脏骤停模型,随机分为常温目标温度管理组(37°C±1°C)、低温目标温度管理组(33°C±1°C×24小时+安慰剂输注)及低温目标温度管理+大剂量丙戊酸组(300 mg/kg IV×1,ROSC后5分钟启动,20分钟输注完毕)。结果显示低温+丙戊酸组72小时生存率显著高于低温组和常温组(p<0.05),心脏骤停后72小时内癫痫发作发生率也显著低于低温组和常温组(p=0.01)。但低温组与低温+丙戊酸组在神经功能良好生存、神经退行性变、HSP70表达及Akt和Erk1/2磷酸化方面无显著差异。作者认为大剂量丙戊酸联合低温目标温度管理可预防心脏骤停后癫痫发作并改善生存,其机制尚待明确。

要点

  • 大鼠窒息性心脏骤停模型中,低温目标温度管理+丙戊酸组72小时生存率显著高于低温组和常温组(p<0.05)。
  • 低温目标温度管理+丙戊酸组心脏骤停后72小时内癫痫发作发生率显著低于低温组和常温组(p=0.01)。
  • 丙戊酸给药方案为300 mg/kg IV×1,ROSC后5分钟启动,20分钟内输注完毕,联合33°C±1°C低温目标温度管理24小时。
  • 低温组与低温+丙戊酸组在神经功能良好生存、神经退行性变、HSP70表达及Akt和Erk1/2磷酸化方面无显著差异。
  • 作者认为丙戊酸联合低温目标温度管理仍是有前景的改善心脏骤停结局的策略,但预防癫痫发作的机制尚待确定。

适用人群与场景

  • 雄性Long Evans大鼠,经复苏成功的窒息性心脏骤停模型。

处置流程与药物剂量

  • 常温目标温度管理组:目标温度37°C±1°C。
  • 低温目标温度管理组:目标温度33°C±1°C维持24小时+安慰剂输注。
  • 低温目标温度管理+丙戊酸组:目标温度33°C±1°C维持24小时,丙戊酸300 mg/kg IV×1,ROSC后5分钟启动,20分钟内输注完毕。

研究设计与关键结果

  • 研究设计为前瞻性、随机、实验研究,研究对象为雄性Long Evans大鼠窒息性心脏骤停复苏后模型,随机分为常温目标温度管理组(37°C±1°C)、低温目标温度管理组(33°C±1°C×24小时+安慰剂输注)和低温目标温度管理+丙戊酸组(300 mg/kg IV×1,ROSC后5分钟启动,20分钟输注完毕)。
  • 72小时生存率:低温目标温度管理+丙戊酸组显著高于低温目标温度管理组和常温目标温度管理组(p<0.05)。
  • 心脏骤停后72小时内癫痫发作发生率:低温目标温度管理+丙戊酸组显著低于低温目标温度管理组和常温目标温度管理组(p=0.01)。
  • 神经功能良好生存、神经退行性变、HSP70表达及Akt和Erk1/2磷酸化:低温目标温度管理组与低温目标温度管理+丙戊酸组之间无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性、随机、实验研究(动物实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在大鼠窒息性心脏骤停模型中,ROSC后5分钟启动丙戊酸300 mg/kg IV×1(20分钟输注)联合33°C±1°C低温目标温度管理24小时,可降低72小时癫痫发作发生率并提高72小时生存率。
  • 作者认为,大剂量丙戊酸联合低温目标温度管理仍是有前景的改善心脏骤停结局的策略,但预防癫痫发作的机制是丙戊酸的抗癫痫作用还是直接神经保护作用尚待确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: High-dose valproic acid in combination with hypothermic-targeted temperature management has been reported to synergistically improve neurologic outcomes after cardiac arrest. This study investigated the potential synergistic mechanisms.

DESIGN: Prospective, randomized, experimental study.

SETTING: University research institution.

SUBJECTS: Male Long Evans rats.

INTERVENTION: Rats resuscitated from asphyxial cardiac arrest were randomized to one of the three groups: normothermic-targeted temperature management (37°C ± 1°C), hypothermic-targeted temperature management (33° ± 1° × 24 hr + placebo infusion), hypothermic-targeted temperature management plus high-dose valproic acid (300 mg/kg IV × 1 initiated 5 min post return of spontaneous circulation and infused over 20 min) (hypothermic-targeted temperature management + valproic acid).

MEASUREMENTS AND MAIN RESULTS: Seventy-two-hour survival was significantly greater with hypothermic-targeted temperature management + valproic acid, compared to hypothermic-targeted temperature management and normothermic-targeted temperature management (p < 0.05). Survival with good neurologic function, neurodegeneration, expression of HSP70, phosphorylation of Akt and Erk1/2 were not significantly different between hypothermic-targeted temperature management and hypothermic-targeted temperature management + valproic acid. The prevalence of seizures during the first 72-hour postcardiac arrest was significantly lower with hypothermic-targeted temperature management + valproic acid compared to hypothermic-targeted temperature management and normothermic-targeted temperature management (p = 0.01).

CONCLUSIONS: High-dose valproic acid combined with hypothermic-targeted temperature management prevents postcardiac arrest seizures and improves survival. It remains to be determined if the mechanism of seizure prevention is through the antiepileptic effect of valproic acid or direct neuroprotection. Overall, the combination of high-dose valproic acid and hypothermic-targeted temperature management remains a promising strategy to improve cardiac arrest outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Oh JS, Tulasi J, Xiaodan R, et al. Valproic Acid Combined With Postcardiac Arrest Hypothermic-Targeted Temperature Management Prevents Delayed Seizures and Improves Survival in a Rat Cardiac Arrest Model. Crit Care Med. 2017. PMID: 28857853. doi:10.1097/CCM.0000000000002690

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。